Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

Maria Tarcela Gler, Vija Skripconoka, Epifanio Sànchez-Garavito, Heping Xiao, José Luis Cabrera, Dante E. Vargas-Vasquez, Mengqiu Gao, Mohamed Awad, Seung-Kyu Park, Tae Sun Shim, Gee Young Suh, Manfred Danilovitš, Hideo Ogata, Anu Kurve, Joon Chang, Katsuhiro Suzuki, Thelma E. Tupasi, Won‐Jung Koh, Barbara Seaworth, Lawrence Geiter, Charles D. Wells

New England Journal of Medicine, 2012

Tropical Disease Foundation, Makati Medical Center, State Education Development Agency, Universidad Privada Sergio Bernales, Shanghai Pulmonary Hospital, Hospital Nacional Cayetano Heredia, Hospital San Hipólito, Beijing Chest Hospital, Masan National Tuberculosis Hospital, Asan Medical Center, Samsung Medical Center, Tartu University Hospital, Fukujuji Hospital, Foundation Center, North Estonia Medical Centre, Severance Hospital, Yonsei University, University Medical Center, NHO Kinki Chuo Chest Medical Center, The University of Texas Health Science Center at Tyler, Otsuka (United States), Pharmaceutical Product Development (United States)

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

732

Citations

View on Google Scholar

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

Abstract

Journal Details

Join JournalsHub

Welcome Back